{"id":"formaldehyde","rwe":[],"_fda":{"id":"0590e5fd-6217-b75a-e063-6294a90acb86","set_id":"0590e5fd-6216-b75a-e063-6294a90acb86","openfda":{"unii":["GRN94TP8YV","AU5C98U4BB","CQV855H5FG","9HB0XUS9TM"],"route":["ORAL"],"spl_id":["0590e5fd-6217-b75a-e063-6294a90acb86"],"brand_name":["INFLUENZINUM"],"spl_set_id":["0590e5fd-6216-b75a-e063-6294a90acb86"],"package_ndc":["0220-5085-41"],"product_ndc":["0220-5085"],"generic_name":["INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)"],"product_type":["HUMAN OTC DRUG"],"substance_name":["INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)","INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)","INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)","INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)"],"manufacturer_name":["Boiron"],"is_original_packager":[true]},"purpose":[""],"version":"1","stop_use":["Stop use and ask a doctor if symptoms persist for more than 3 days or worsen."],"warnings":[""],"questions":["1-800-BOIRON-1 (1-800-264-7661), BoironUSA.com Info@Boiron.com Distributed by Boiron, Inc. Newtown Square, PA 19073"],"effective_time":"20230917","active_ingredient":["Active ingredient** Influenzinum 12C HPUS See product name on front panel (contains 0.443 mg of the active ingredient per pellet)"],"inactive_ingredient":["lactose, sucrose"],"indications_and_usage":["Relieves after effects of flu or flu-like symptoms * See symptoms on front panel."],"spl_unclassified_section":["Do not use if pellet dispenser seal is broken. Contains approx 80 pellets. How to dispense pellets? Turn tube upside down. Twist until 5 pellets are dispensed into cap. Carefully remove the cap and use it to pour pellets under the tongue. *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED. **C,K,CK, and X are homeopathic dilutions: see BoironUSA.com/info for details. The letters \"HPUS\" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States."],"dosage_and_administration":["Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor."],"spl_product_data_elements":["INFLUENZINUM INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) LACTOSE, UNSPECIFIED FORM INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) SUCROSE"],"pregnancy_or_breast_feeding":["If pregnant or breast-feeding, ask a health professional before use"],"keep_out_of_reach_of_children":["Keep out of reach of children."],"package_label_principal_display_panel":["label"]},"tags":[{"label":"Standardized Chemical Allergen","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Liquid","category":"form"},{"label":"Active","category":"status"},{"label":"Influenza","category":"indication"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Disinfectants","category":"pharmacology"},{"label":"Fixatives","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG HYPERSENSITIVITY","source":"FDA FAERS","actionTaken":"26 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"12 reports"},{"date":"","signal":"INFLUENZA","source":"FDA FAERS","actionTaken":"10 reports"},{"date":"","signal":"ALLERGY TO CHEMICALS","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"INFUSION RELATED REACTION","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"PHARYNGITIS STREPTOCOCCAL","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"RESPIRATORY RATE INCREASED","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"BLOOD TEST ABNORMAL","source":"FDA FAERS","actionTaken":"8 reports"},{"date":"","signal":"JOINT STIFFNESS","source":"FDA FAERS","actionTaken":"8 reports"},{"date":"","signal":"PARATHYROID HYPERPLASIA","source":"FDA FAERS","actionTaken":"8 reports"}],"commonSideEffects":[{"effect":"Pain (injection-site)","drugRate":"50%","severity":"common","organSystem":""},{"effect":"Redness (injection-site)","drugRate":"25%","severity":"common","organSystem":""},{"effect":"Irritability","drugRate":"25%","severity":"common","organSystem":""},{"effect":"Drowsiness","drugRate":"25%","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"30%","severity":"common","organSystem":""},{"effect":"Myalgia","drugRate":"20%","severity":"common","organSystem":""},{"effect":"Malaise","drugRate":"10%","severity":"common","organSystem":""}],"seriousAdverseEvents":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=formaldehyde","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:58:51.337281+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:59:12.087364+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:58:59.005597+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=formaldehyde","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:58:59.768256+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:58:49.043164+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:59:06.563079+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:58:49.043198+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:59:01.327223+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1255/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:59:00.243523+00:00"}},"allNames":"formol","offLabel":[],"synonyms":["formol","formaldehyde","formalin"],"timeline":[],"aiSummary":"Formaldehyde (Formol) is a marketed drug primarily indicated for the relief of flu or flu-like symptoms, though it operates by triggering an immune response to aid in diagnosing allergies or other conditions. A key strength is its unique mechanism of action, which differentiates it in the diagnostic space. The primary risk is the expiration of the key composition patent in 2028, which could lead to increased competition.","approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Formol","ecosystem":[{"indication":"Influenza","otherDrugs":[{"name":"baloxavir marboxil","slug":"baloxavir-marboxil","company":"Genentech Inc"},{"name":"oseltamivir","slug":"oseltamivir","company":"Roche"},{"name":"peramivir","slug":"peramivir","company":"Biocryst"},{"name":"zanamivir","slug":"zanamivir","company":"Glaxosmithkline"}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"Standardized Chemical Allergen","explanation":"","oneSentence":"","technicalDetail":"Formol acts as a hapten, a small molecule that binds to a larger protein to form an antigen, which is then recognized by the immune system and triggers an immune response."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3244","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=formaldehyde","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=formaldehyde","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:38:01.138368","_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:59:12.087767+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"formaldehyde","indications":{"approved":[{"id":"formaldehyde-flu-or-flu-like-symptoms-relie","name":"Flu or flu-like symptoms relief","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Not specified","pivotalTrial":null,"restrictions":[],"patientPopulation":"Not specified","diagnosticRequired":null,"brandNameForIndication":"Formol"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06278285","phase":"NA","title":"Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2024-03-06","conditions":["Obesity"],"enrollment":40,"completionDate":"2027-03-06"},{"nctId":"NCT07067138","phase":"NA","title":"A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-02-23","conditions":["Breast Cancer","Breast Carcinoma","Cancer of the Breast","Malignant Neoplasm of Breast"],"enrollment":175,"completionDate":"2029-08-04"},{"nctId":"NCT07459569","phase":"NA","title":"Diagnostic Performance and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy in Diagnosing Tuberculous Mediastinal Lymphadenitis: a Randomised Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2026-05","conditions":["Tuberculosis","Mediastinal and Hilar Lymph Node Enlargement"],"enrollment":108,"completionDate":"2027-05"},{"nctId":"NCT07421622","phase":"NA","title":"Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block","status":"NOT_YET_RECRUITING","sponsor":"Sheikh Zayed Federal Postgraduate Medical Institute","startDate":"2026-03-01","conditions":["Epistaxis Nosebleed","Greater Palatine Foramen"],"enrollment":40,"completionDate":"2027-02-28"},{"nctId":"NCT05475366","phase":"NA","title":"Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures","status":"RECRUITING","sponsor":"Institut Curie","startDate":"2022-12-12","conditions":["Carcinoma, Pancreatic Ductal","Prognosis"],"enrollment":85,"completionDate":"2028-12-11"},{"nctId":"NCT06222138","phase":"NA","title":"Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"Institut Claudius Regaud","startDate":"2024-08-27","conditions":["Glioblastoma"],"enrollment":80,"completionDate":"2029-11"},{"nctId":"NCT03420508","phase":"PHASE2","title":"Treating Patients With Melanoma and ALK Alterations With Ensartinib","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-01-10","conditions":["Melanoma"],"enrollment":18,"completionDate":"2027-01"},{"nctId":"NCT06283238","phase":"","title":"Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2025-04-16","conditions":["GastroEsophageal Cancer"],"enrollment":0,"completionDate":"2027-03-25"},{"nctId":"NCT07318298","phase":"NA","title":"Effect of Injectable Hyaluronic Acid (HYADENT BG (HA)) on Bone Healing in Extraction Sockets","status":"RECRUITING","sponsor":"Jordan University of Science and Technology","startDate":"2024-08-01","conditions":["The Application of Hyaluronic Acid on Teeth Bone Healing. Hyaluronic Acid Which is Widely Used in Medicine for Joint, Eye Care, Wound Healing"],"enrollment":20,"completionDate":"2026-04-30"},{"nctId":"NCT04613206","phase":"PHASE2","title":"High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-01-11","conditions":["Immunization; Infection","Transplantation Infection","Influenza","Solid Organ Transplant"],"enrollment":396,"completionDate":"2026-12-31"},{"nctId":"NCT06406387","phase":"","title":"ATRX/DAXX in EUS-FNB Specimens of Pan-NETs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2024-06-01","conditions":["Pancreatic Neuroendocrine Tumor"],"enrollment":100,"completionDate":"2029-11-30"},{"nctId":"NCT04000477","phase":"NA","title":"Comparison of 2 Types of Cervical Specimens in Patients With a Pathological Screening Smear","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2019-11-05","conditions":["Cervical Cancer","Pathological Screening Smear"],"enrollment":3,"completionDate":"2019-11-25"},{"nctId":"NCT02823860","phase":"NA","title":"Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2016-02-12","conditions":["Digestive Peritoneal Carcinomatosis"],"enrollment":2186,"completionDate":"2022-10-13"},{"nctId":"NCT06606028","phase":"","title":"Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-10-09","conditions":["Squamous Cell Carcinoma of Head and Neck","Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)","Squamous Cell Carcinoma of Skin","Cutaneous Squamous Cell Carcinoma (CSCC)"],"enrollment":250,"completionDate":"2029-12-30"},{"nctId":"NCT07271914","phase":"NA","title":"PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors","status":"NOT_YET_RECRUITING","sponsor":"Ospedale Santa Croce-Carle Cuneo","startDate":"2026-02","conditions":["Early Stage Ovarian Tumors","Peritoneal Carcinosis"],"enrollment":390,"completionDate":"2032-08"},{"nctId":"NCT07270796","phase":"PHASE1","title":"Safety and Immunogenicity Study of the DuoChol Oral Cholera Vaccine in Healthy Participants","status":"NOT_YET_RECRUITING","sponsor":"International Vaccine Institute","startDate":"2025-12","conditions":["Cholera Vaccination Reaction"],"enrollment":60,"completionDate":"2026-03"},{"nctId":"NCT05215327","phase":"PHASE2","title":"High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2022-11-08","conditions":["Immunization; Infection","Transplantation Infection","Influenza"],"enrollment":270,"completionDate":"2027-12-31"},{"nctId":"NCT07264504","phase":"NA","title":"Experimentation of Formaldehyde Purification by Plants in the Anatomy and Cytology Department","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2024-09-25","conditions":["Formaldehyde","Pathological Anatomy and Cytology"],"enrollment":30,"completionDate":"2026-05"},{"nctId":"NCT07230717","phase":"NA","title":"Evaluation of Pulpotomy Versus Pulpectomy in Primary Molars With Irreversible Pulpitis or Necrotic Pulp","status":"NOT_YET_RECRUITING","sponsor":"Ajman University","startDate":"2025-12-01","conditions":["Pulp Therapy","Pulpitis - Irreversible","Pulp Necrosis"],"enrollment":30,"completionDate":"2027-05-01"},{"nctId":"NCT03877796","phase":"","title":"Clinical Pre-screening Protocol for Ovarian Cancer","status":"RECRUITING","sponsor":"Allarity Therapeutics","startDate":"2019-04-11","conditions":["Ovarian Cancer"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT07192458","phase":"PHASE2","title":"High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-09-17","conditions":["Immunization; Infection|Transplantation Infection|Influenza","Influenza"],"enrollment":60,"completionDate":"2029-12"},{"nctId":"NCT06131424","phase":"","title":"NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-04-23","conditions":["HER2-negative"],"enrollment":1151,"completionDate":"2025-05-19"},{"nctId":"NCT07130110","phase":"NA","title":"BAL Contribution to Lung Cryo-TBB in ILD","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2023-12-20","conditions":["Bronchoalveolar Lavage (BAL)","Transbronchial Cryobiopsy","Interstitial Lung Disease (ILD)"],"enrollment":127,"completionDate":"2024-09-30"},{"nctId":"NCT05049837","phase":"","title":"PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-04-25","conditions":["Lung Cancer","Cancer of Thorax"],"enrollment":7200,"completionDate":"2025-12-31"},{"nctId":"NCT06645236","phase":"NA","title":"DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit","status":"RECRUITING","sponsor":"QIAGEN Gaithersburg, Inc","startDate":"2023-12-22","conditions":["Metastatic Colorectal Cancer (mCRC)"],"enrollment":600,"completionDate":"2030-10-31"},{"nctId":"NCT06449989","phase":"","title":"Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer","status":"RECRUITING","sponsor":"Blokhin's Russian Cancer Research Center","startDate":"2024-04-01","conditions":["Colorectal Cancer Metastatic","Brain Metastases, Adult","Ras (KRAS or NRAS) Gene Mutation","BRAF Gene Mutation","HER2 Gene Mutation","MSI"],"enrollment":30,"completionDate":"2027-09"},{"nctId":"NCT05837455","phase":"PHASE2","title":"NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-05-30","conditions":["Breast Cancer","Cancer of the Breast"],"enrollment":81,"completionDate":"2027-11-30"},{"nctId":"NCT07047482","phase":"","title":"Clinicopathological Value of p16 Expression in Colorectal Carcinoma","status":"RECRUITING","sponsor":"Sohag University","startDate":"2025-05-01","conditions":["Colorectal Carcinoma"],"enrollment":50,"completionDate":"2026-12-30"},{"nctId":"NCT06314958","phase":"","title":"Stage II/III Colorectal Cancer Recurrence","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-03-15","conditions":["Colorectal Cancer","Colorectal Adenocarcinoma","Colorectal Cancer Stage II","Colorectal Cancer Stage III","Colorectal Cancer Recurrent"],"enrollment":400,"completionDate":"2026-06-18"},{"nctId":"NCT06314971","phase":"","title":"Predicting Local and Distant Recurrence in T1 Colorectal Cancer","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2023-03-15","conditions":["Colorectal Cancer","Colorectal Neoplasms","Colorectal Adenocarcinoma","Colorectal Cancer Stage I","Colorectal Neoplasms Malignant","Colorectal Cancer Recurrent"],"enrollment":138,"completionDate":"2025-06-30"},{"nctId":"NCT06978621","phase":"PHASE3","title":"Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV","status":"RECRUITING","sponsor":"Chiang Mai University","startDate":"2025-05-25","conditions":["Hepatitis A","Hepatitis A Virus","Vaccine-Preventable Diseases"],"enrollment":36,"completionDate":"2025-09-30"},{"nctId":"NCT04025515","phase":"","title":"Molecular Profiling Project","status":"RECRUITING","sponsor":"National Cancer Centre, Singapore","startDate":"2019-01-11","conditions":["Lung Cancer","Non-Small Cell Lung Cancer"],"enrollment":500,"completionDate":"2025-12-25"},{"nctId":"NCT06860295","phase":"","title":"\"Immunoregulation in Atherosclerosis: A Single-Cell RNA Sequencing Study\"","status":"NOT_YET_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2025-06-25","conditions":["Atherosclerosis of Coronary Artery"],"enrollment":30,"completionDate":"2027-04-25"},{"nctId":"NCT06994611","phase":"NA","title":"Fine-needle Biopsy Combined With Macroscopic On-site Evaluation for Diagnosis of Solid Pancreatic Lesions","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-06-25","conditions":["Pancreatic Diseases"],"enrollment":148,"completionDate":"2026-08-26"},{"nctId":"NCT07003776","phase":"","title":"Evaluation of Tumor Budding In Colorectal Adenocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2025-10-01","conditions":["Colorectal Adenocarcinoma"],"enrollment":50,"completionDate":"2026-05-03"},{"nctId":"NCT05357768","phase":"","title":"Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2019-06-11","conditions":["Undifferentiated Round Cell Sarcoma"],"enrollment":260,"completionDate":"2028-12-31"},{"nctId":"NCT06222164","phase":"","title":"The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research","status":"RECRUITING","sponsor":"Invivoscribe, Inc.","startDate":"2024-03-30","conditions":["Hematologic Diseases"],"enrollment":2000,"completionDate":"2027-06-30"},{"nctId":"NCT06298708","phase":"PHASE3","title":"Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents","status":"COMPLETED","sponsor":"Chiang Mai University","startDate":"2024-04-27","conditions":["HAV","Hepatitis A","Hep A","Vaccine-Preventable Diseases"],"enrollment":120,"completionDate":"2024-12-09"},{"nctId":"NCT05041335","phase":"NA","title":"Wet Heparinized Suction for Abdominal Cancer","status":"NOT_YET_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2026-03-15","conditions":["Cancer of Pancreas","Cancer of Stomach","Cancer of Esophagus","Cancer of Liver","Cancer"],"enrollment":42,"completionDate":"2027-01-12"},{"nctId":"NCT05734430","phase":"","title":"Genetics of Appendix Cancer Study","status":"RECRUITING","sponsor":"Andreana Holowatyj, PhD, MSCI","startDate":"2022-11-11","conditions":["Appendix Cancer","Appendiceal Cancer","Appendiceal Neoplasms","Appendiceal Mucinous Neoplasm","Appendiceal Adenocarcinoma","Appendiceal Carcinoid Tumor","Appendiceal Neoplasm Malignant Secondary","Appendix Adenocarcinoma","Appendix Mucinous Neoplasm","Appendix Tumor","Appendix Cancer Metastatic","Appendix NET","Low-Grade Appendix Mucinous Neoplasm","High Grade Appendix Mucinous Neoplasm","High Grade Appendix Mucinous Adenocarcinoma"],"enrollment":700,"completionDate":"2034-11"},{"nctId":"NCT06913699","phase":"","title":"The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2024-04-01","conditions":["Non-alcoholic Fatty Liver Disease (NAFLD)"],"enrollment":6,"completionDate":"2026-05-31"},{"nctId":"NCT06014619","phase":"","title":"Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2023-08-01","conditions":["Skin Cancer","Complication","Complication of Surgical Procedure","Complication,Postoperative","Recurrence","Recurrent Disease","Cutaneous Squamous Cell Carcinoma","Basal Cell Carcinoma","Lentigo Maligna","Lentigo Maligna Melanoma"],"enrollment":500,"completionDate":"2025-06"},{"nctId":"NCT06911801","phase":"","title":"In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-04","conditions":["Vulvar Squamous Cell Carcinoma"],"enrollment":90,"completionDate":"2026-11"},{"nctId":"NCT05347745","phase":"NA","title":"Therascreen® KRAS RGQ PCR Kit","status":"COMPLETED","sponsor":"QIAGEN Gaithersburg, Inc","startDate":"2022-01-07","conditions":["Colo-rectal Cancer"],"enrollment":219,"completionDate":"2023-04-30"},{"nctId":"NCT05947071","phase":"PHASE2","title":"High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-09-26","conditions":["Immunization; Infection","Transplantation Infection","Influenza"],"enrollment":312,"completionDate":"2027-09-01"},{"nctId":"NCT04600466","phase":"","title":"Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2021-01-22","conditions":["Gastric Cancer"],"enrollment":150,"completionDate":"2030-01-22"},{"nctId":"NCT06876571","phase":"","title":"Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay","status":"NOT_YET_RECRUITING","sponsor":"Invivoscribe, Inc.","startDate":"2025-06-02","conditions":["T-Cell Lymphoproliferative Disorder"],"enrollment":250,"completionDate":"2025-12-06"},{"nctId":"NCT06482359","phase":"PHASE2,PHASE3","title":"Lot Consistency Study of COVID-19 and Influenza Combination Vaccine","status":"WITHDRAWN","sponsor":"Novavax","startDate":"2025-02-01","conditions":["COVID-19","Influenza"],"enrollment":0,"completionDate":"2026-05-17"},{"nctId":"NCT06852157","phase":"NA","title":"Evaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precancerous Lesions of the Cervix","status":"NOT_YET_RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2025-02","conditions":["Cervix Cancer"],"enrollment":100,"completionDate":"2026-02"},{"nctId":"NCT06845982","phase":"NA","title":"Anatomopathological Evaluation of a New Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2025-03-01","conditions":["Uterine Fibroids (UF)"],"enrollment":250,"completionDate":"2028-10-01"},{"nctId":"NCT06836271","phase":"PHASE2","title":"Cleaning the Biopsy Needle in TRUS Bx","status":"NOT_YET_RECRUITING","sponsor":"Hitit University","startDate":"2025-03-01","conditions":["Prostatic Cancer"],"enrollment":200,"completionDate":"2025-06-30"},{"nctId":"NCT06809478","phase":"NA","title":"Clinical and Radiographic Evaluation of Chitosan Versus Formocresol After Vital Pulpotomy of Primary Molars","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-04","conditions":["Pulpitis - Reversible","Pulpotomy"],"enrollment":50,"completionDate":"2026-07"},{"nctId":"NCT06796634","phase":"NA","title":"Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2024-08-21","conditions":["Cold Atmospheric Plasma (CAP)","J-Plasma","Peritoneal Tumor"],"enrollment":5,"completionDate":"2025-04-01"},{"nctId":"NCT04472013","phase":"","title":"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-08-12","conditions":["COVID-19 Disease"],"enrollment":40,"completionDate":"2022-11-09"},{"nctId":"NCT05364788","phase":"","title":"Molecular Characterisation of Appendiceal Cancer","status":"RECRUITING","sponsor":"The Christie NHS Foundation Trust","startDate":"2024-02-04","conditions":["Appendiceal Cancer"],"enrollment":100,"completionDate":"2025-07-03"},{"nctId":"NCT05513716","phase":"","title":"Molecular Characterisation of Colorectal Cancer Peritoneal Metastases","status":"RECRUITING","sponsor":"The Christie NHS Foundation Trust","startDate":"2024-02-04","conditions":["Colorectal Cancer Metastatic"],"enrollment":200,"completionDate":"2025-07-03"},{"nctId":"NCT06741852","phase":"NA","title":"Confocal Laser Endomicroscopy Assisted Endobronchial Ultrasound-guided- Transbronchial Mediastinal Cryobiopsy Via a Tunnel for Diagnosing Mediastinal Lymphadenopathy","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2025-01-01","conditions":["Mediastinal Lymphadenopathy"],"enrollment":98,"completionDate":"2026-12-31"},{"nctId":"NCT06717061","phase":"","title":"Composed Abdominal Wall Analysis. Collecting Tissue and Blood From Patients Undergoing Elective Laparosopic Cholecystectomy. Objective to Describe the Normal Abdominal Wall","status":"ENROLLING_BY_INVITATION","sponsor":"Region Västerbotten","startDate":"2024-04-10","conditions":["Hernia","Abdominal Wall"],"enrollment":40,"completionDate":"2026-11-18"},{"nctId":"NCT05348187","phase":"NA","title":"Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit","status":"COMPLETED","sponsor":"QIAGEN Gaithersburg, Inc","startDate":"2019-07-01","conditions":["Non-Small Cell Lung Cancer","Colorectal Cancer"],"enrollment":309,"completionDate":"2020-11-23"},{"nctId":"NCT05360225","phase":"","title":"Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit","status":"COMPLETED","sponsor":"QIAGEN Gaithersburg, Inc","startDate":"2020-04-02","conditions":["Non Small Cell Lung Cancer"],"enrollment":5000,"completionDate":"2022-05-26"},{"nctId":"NCT05347797","phase":"NA","title":"Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit","status":"COMPLETED","sponsor":"QIAGEN Gaithersburg, Inc","startDate":"2020-03-13","conditions":["Non-small Cell Lung Cancer"],"enrollment":495,"completionDate":"2021-04-22"},{"nctId":"NCT03917654","phase":"PHASE2","title":"Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-04-24","conditions":["Malaria"],"enrollment":1301,"completionDate":"2022-10-31"},{"nctId":"NCT06606301","phase":"","title":"Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma","status":"COMPLETED","sponsor":"Combined Military Hospital, Pakistan","startDate":"2023-08-26","conditions":["Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer"],"enrollment":61,"completionDate":"2023-12-28"},{"nctId":"NCT03485924","phase":"NA","title":"EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2018-04-12","conditions":["Fine Needle Aspiration","Pancreatic Mass"],"enrollment":40,"completionDate":"2023-07-26"},{"nctId":"NCT06579456","phase":"NA","title":"Evaluation in a Multimodal Structured Curriculum of Laparoscopic Surgery","status":"COMPLETED","sponsor":"University of Los Andes, Columbia","startDate":"2022-01-28","conditions":["Medical Education","Laparoscopic Surgery"],"enrollment":37,"completionDate":"2022-09-20"},{"nctId":"NCT06262620","phase":"NA","title":"The Comparison of EBUS-TBNA, TBMC Via a Tunnel, and TBFB Via a Tunnel in Diagnosing Mediastinal Lymphadenopathy.","status":"RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2024-03-01","conditions":["Lymphadenopathy Hilar","Lymphadenopathy Mediastinal"],"enrollment":552,"completionDate":"2026-02-18"},{"nctId":"NCT06039956","phase":"NA","title":"De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria","status":"NOT_YET_RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2025-11-01","conditions":["Breast Cancer","Axilla; Breast"],"enrollment":100,"completionDate":"2027-05-31"},{"nctId":"NCT06536946","phase":"","title":"B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers","status":"RECRUITING","sponsor":"Sohag University","startDate":"2024-06-01","conditions":["Cutaneous Squamous Cell Carcinoma"],"enrollment":50,"completionDate":"2025-09-30"},{"nctId":"NCT05504772","phase":"","title":"Precision Medicine for Every Child With Cancer","status":"RECRUITING","sponsor":"Australian & New Zealand Children's Haematology/Oncology Group","startDate":"2022-12-16","conditions":["Childhood Cancer","Childhood Solid Tumor","Childhood Brain Tumor","Childhood Leukemia","Refractory Cancer","Relapsed Cancer"],"enrollment":3500,"completionDate":"2030-07"},{"nctId":"NCT06499168","phase":"","title":"Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-08","conditions":["Locally Advanced Breast Cancer"],"enrollment":45,"completionDate":"2027-08"},{"nctId":"NCT06494800","phase":"","title":"Added Value of PET/CT in Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2024-07-15","conditions":["Lung Cancer"],"enrollment":30,"completionDate":"2025-12-01"},{"nctId":"NCT06466343","phase":"NA","title":"Immunohistopathologic Findings of Cesarean Scar Niche","status":"RECRUITING","sponsor":"Sohag University","startDate":"2024-06-01","conditions":["Cesarean Scar Niche"],"enrollment":50,"completionDate":"2025-12-30"},{"nctId":"NCT06436677","phase":"","title":"A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2024-05-09","conditions":["Cutaneous T-Cell Lymphoma/Mycosis Fungoides","Cutaneous T Cell Lymphoma"],"enrollment":100,"completionDate":"2030-12-31"},{"nctId":"NCT06436027","phase":"","title":"Molecular Diagnosis of Heart Allograft Rejection Using Intra-Graft Targeted Gene Expression Profiling.","status":"COMPLETED","sponsor":"Paris Translational Research Center for Organ Transplantation","startDate":"2021-11-10","conditions":["Heart Transplant Rejection"],"enrollment":496,"completionDate":"2023-12-15"},{"nctId":"NCT06424379","phase":"","title":"BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-01-01","conditions":["Non Hodgkin Lymphoma","Follicular Lymphoma","Marginal Zone Lymphoma","Diffuse Large B Cell Lymphoma"],"enrollment":135,"completionDate":"2025-06-30"},{"nctId":"NCT06421402","phase":"","title":"K-HEALTH in AIR - Barcelona Pilot - Cohort","status":"ENROLLING_BY_INVITATION","sponsor":"Institut d'Investigacions Biomèdiques August Pi i Sunyer","startDate":"2023-10-13","conditions":["Severe Asthma","COPD"],"enrollment":200,"completionDate":"2026-08-31"},{"nctId":"NCT04155242","phase":"NA","title":"The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia","status":"RECRUITING","sponsor":"University of Cambridge","startDate":"2020-09-01","conditions":["Barrett's Oesophagus"],"enrollment":147,"completionDate":"2024-12-01"},{"nctId":"NCT06231082","phase":"NA","title":"Bloody or Well Done. How Would You Like Your Liver Biopsy, Sir?","status":"RECRUITING","sponsor":"Carol Davila University of Medicine and Pharmacy","startDate":"2024-05-06","conditions":["Liver Disease Parenchymal"],"enrollment":78,"completionDate":"2024-12"},{"nctId":"NCT05386810","phase":"PHASE3","title":"Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2020-11-05","conditions":["Poliomyelitis"],"enrollment":1572,"completionDate":"2023-07-20"},{"nctId":"NCT04867590","phase":"NA","title":"A Study Comparing the Effectiveness of EndoRotor Versus Radiofrequency in Treating Barrett's Esophagus","status":"RECRUITING","sponsor":"University Hospital, Angers","startDate":"2022-03-25","conditions":["Barrett Esophagus","Dysplasia"],"enrollment":140,"completionDate":"2027-05"},{"nctId":"NCT04411810","phase":"NA","title":"SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2020-08-20","conditions":["Skin Cancer"],"enrollment":149,"completionDate":"2023-03-04"},{"nctId":"NCT06313385","phase":"NA","title":"Investigating the Impact of Indocyanine Green Titration on Fluorescent Intensity in Free Flap : An Exploration of Alternative Indicators","status":"ACTIVE_NOT_RECRUITING","sponsor":"Indonesia University","startDate":"2023-01-01","conditions":["Free Flap","Indocyanine Green","Microsurgery","Temperature Change, Body"],"enrollment":63,"completionDate":"2024-03-29"},{"nctId":"NCT03295175","phase":"","title":"Distribution of Smooth Muscle In Dartos In The Non Conspicuous Penis","status":"WITHDRAWN","sponsor":"Hospital Universitario San Ignacio","startDate":"2017-09-21","conditions":["Congenital Urogenital Anomaly"],"enrollment":0,"completionDate":"2024-03-12"},{"nctId":"NCT06271980","phase":"","title":"Early-Onset Colorectal Cancer Recurrence","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2023-04-15","conditions":["Colorectal Cancer Recurrent","Colorectal Cancer","Colorectal Neoplasms","Colorectal Adenocarcinoma","Colorectal Cancer Stage I","Colorectal Cancer Stage II","Colorectal Cancer Stage III"],"enrollment":177,"completionDate":"2024-02-01"},{"nctId":"NCT02872831","phase":"NA","title":"Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle","status":"TERMINATED","sponsor":"Thomas Jefferson University","startDate":"2016-07","conditions":["Pancreatic Cancer","Lymphadenopathy","Cholangiocarcinoma"],"enrollment":376,"completionDate":"2017-11"},{"nctId":"NCT06261073","phase":"NA","title":"Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-03-15","conditions":["Vitiligo"],"enrollment":40,"completionDate":"2025-03-01"},{"nctId":"NCT06251726","phase":"","title":"Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-04","conditions":["Colorectal Cancer"],"enrollment":310,"completionDate":"2024-12"},{"nctId":"NCT04112693","phase":"NA","title":"Assessment of the Neuro-glio-epithelial Unit (NGEU) in Biopsies Taken During Peroral Endoscopic Myotomy (POEM) for Achalasia: a Feasibility and Safety Study.","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2019-11-21","conditions":["Esophageal Achalasia"],"enrollment":28,"completionDate":"2023-11-13"},{"nctId":"NCT04167605","phase":"","title":"Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases","status":"UNKNOWN","sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","startDate":"2020-01-13","conditions":["Breast Cancer Metastatic","Bone Metastases"],"enrollment":30,"completionDate":"2024-11-12"},{"nctId":"NCT05837585","phase":"NA","title":"The Effectiveness of Air Quality Sensor in Elderly Residential Setting","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2023-06-06","conditions":["Technology","Signs and Symptoms, Respiratory"],"enrollment":60,"completionDate":"2024-01-31"},{"nctId":"NCT06185426","phase":"EARLY_PHASE1","title":"Histopathological, Biochemical And Electrophysiological Evaluation Of Single Or Combined Use Of Diode Laser/Steroid Treatment On Facial Nerve Injury","status":"UNKNOWN","sponsor":"Recep Tayyip Erdogan University","startDate":"2021-01-01","conditions":["Nerve Injury","Laser Therapy","Methylprednisolone","Facial Nerve Injuries"],"enrollment":35,"completionDate":"2024-02-01"},{"nctId":"NCT03034473","phase":"NA","title":"Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.","status":"UNKNOWN","sponsor":"University Medical Center Goettingen","startDate":"2011-08","conditions":["Locally Advanced Rectal Cancer"],"enrollment":200,"completionDate":"2024-08"},{"nctId":"NCT04264702","phase":"","title":"BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer","status":"UNKNOWN","sponsor":"Natera, Inc.","startDate":"2020-04-24","conditions":["Colorectal Cancer","Colon Cancer"],"enrollment":1788,"completionDate":"2025-09"},{"nctId":"NCT06158061","phase":"NA","title":"Assessment of Serum and Tissue Tryptase Levels in Acne Vulgaris Patients","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-01-24","conditions":["Acne Vulgaris"],"enrollment":90,"completionDate":"2024-08-15"},{"nctId":"NCT04675281","phase":"","title":"Pathological Findings of Fatal COVID-19","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2020-04-22","conditions":["SARS-CoV-2","Covid19","Pathology","Intensive Care Units","Respiratory Distress Syndrome"],"enrollment":170,"completionDate":"2021-03-03"},{"nctId":"NCT06147960","phase":"","title":"Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-11","conditions":["Cancer of Cervix","Apoptosis"],"enrollment":180,"completionDate":"2024-11"},{"nctId":"NCT06117956","phase":"NA","title":"Helicobacter Pylori in Patients With Chronic Tonsillits Prepared for Tonsillectomy","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2023-10-01","conditions":["Helicobacter Pylori Infection in Patients With Chronic Tonsillits"],"enrollment":100,"completionDate":"2024-04-30"},{"nctId":"NCT04893356","phase":"","title":"Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)","status":"UNKNOWN","sponsor":"National Cancer Institute, Naples","startDate":"2021-01-20","conditions":["Sarcoma"],"enrollment":75,"completionDate":"2025-01-20"},{"nctId":"NCT04737382","phase":"NA","title":"Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.","status":"UNKNOWN","sponsor":"The Netherlands Cancer Institute","startDate":"2019-08-22","conditions":["Non-small-cell Lung Carcinoma"],"enrollment":200,"completionDate":"2024-08-22"},{"nctId":"NCT06071585","phase":"","title":"Monocentric Retrospective Observational Study for Validation of Meta-analysis of the Metatrascryptome and Transcriptome of Eosynophyl Esophagitis","status":"UNKNOWN","sponsor":"IRCCS San Raffaele","startDate":"2023-11-01","conditions":["Eosinophilic Esophagitis"],"enrollment":105,"completionDate":"2024-11-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Liquid","formulations":[{"form":"LIQUID","route":"ORAL","productName":"Dairy Allergen Mix"}]},"crossReferences":{"NUI":"N0000147328","MMSL":"286","NDDF":"003204","UNII":"1HG84L3525","VUID":"4019061","CHEBI":"CHEBI:16842","VANDF":"4019061","RXNORM":"314636","UMLSCUI":"C0016564","chemblId":"CHEMBL1255","ChEMBL_ID":"CHEMBL1255","KEGG_DRUG":"D00017","DRUGBANK_ID":"DB03843","PDB_CHEM_ID":" FLH","PUBCHEM_CID":"712","SNOMEDCT_US":"111095003","IUPHAR_LIGAND_ID":"4196","MESH_DESCRIPTOR_UI":"D005557"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":27146,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:59:12.087767+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}